• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Horizon Therapeutics plc

Headquarters: Dublin, Ireland
Website: N/A
Year Founded: 2008
Status: Acquired

BioCentury | Apr 25, 2025
Data Byte

CHMP recommends six orphan medicines

Seven new products get positive opinions in April
BioCentury | Mar 27, 2025
Data Byte

Immunology takeouts led by IgA nephropathy, IBD  

Seven of 11 $1B+ immunology acquisitions focused on two diseases
BioCentury | Feb 1, 2025
Finance

Investors with deep China roots lead NewCo surge, inspiring Western VCs

Led by Orbimed, LAV, Boyu, biotech’s Asia ‘NewCo Model’ goes global
BioCentury | Jan 30, 2025
Management Tracks

Wyman joins Scholar Rock

Plus: Danilkowicz to lead commercial at Alumis and an update from Precision
BioCentury | Dec 5, 2024
Finance

Broadening Versant’s obesity portfolio, Antag plots clinical path with €80M

Also in BioCentury’s weekly Venture Report: Formela stepping back from Atlas’ new fund, nine-digit rounds for Nuvig and Maze, and more
BioCentury | Aug 24, 2024
Deals

Pharma deals pivot from high-risk modalities, targets

BioCentury’s analysis of 12 months of dealmaking between biotechs and top pharmas
BioCentury | May 9, 2024
Management Tracks

C-suite changes at Acelyrin could signal reprioritizations in pipeline

With CEO Shao-Lee Lin leaving, the company said it’s aiming to preserve cash resources, with a series of decision-driving clinical catalysts on the way
BioCentury | Apr 4, 2024
Management Tracks

Upstream names new CEO, CFO and COO

Plus: Acadia hires Elizabeth Thompson as head of R&D, and updates from Insitro, Fractyl, Adarx and more
BioCentury | Mar 26, 2024
Management Tracks

Former BioMarin CEO Bienaimé named chair of Owkin

Plus: Dyne shares slip with CEO departing, and updates from Ardelyx and ProKidney
BioCentury | Feb 23, 2024
Product Development

Amgen sees rare diseases as ‘fourth pillar’ of growth, driven by pair of 2022 deals

The big biotech spotlights pipeline, outlines commercial steps critical for drugs from Horizon, ChemoCentryx takeouts to reach more patients
Items per page:
1 - 10 of 107
Help Center
Username
Request Training
Submit Data Correction
Ask a Question